Biotech News
-
DIAGNOS Welcomes Founder of National Vision Associates, Ed Weiner, to its Advisory Board for the United States
June 10, 2025 (Source) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A),…
-
Voyageur Enters Revenue Stage with First Commercial Sale of Barium Contrast Agents
June 4, 2025 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) (“Voyageur” or the “Company”), a radiology contrast…
-
DIAGNOS Welcomes Former White House Economic Adviser Dr. Tomas J. Philipson to its Advisory Board for the US Market
June 4, 2025 (Source) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A),…
-
DIAGNOS Announces the Engagement of Allele Capital Partners
May 23, 2025 (Source) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A),…
-
DIAGNOS Announces Amendment to Convertible Debentures
May 20, 2025 (Source) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A),…
-
Voyageur Pharmaceuticals Announces Appointment of Ethan Mohan as Executive Vice President
May 12, 2025 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) (“Voyageur” or the “Company”) a radiology contrast…
-
Brent Willis to Spotlight “Radiology’s Hidden Critical Minerals Crisis—And How Voyageur Is Solving It” at CMI Summit IV
TORONTO, ONTARIO – May 8, 2025 – The Critical Minerals Institute (CMI) is delighted to announce that Brent Willis B.Sc. Eng., President,…
-
Brent Willis to Spotlight “Radiology’s Hidden Critical Minerals Crisis—And How Voyageur Is Solving It” at CMI Summit IV
TORONTO, ONTARIO – May 8, 2025 – The Critical Minerals Institute (CMI) is delighted to announce that Brent Willis B.Sc. Eng., President,…
-
Voyageur Pharmaceuticals Announces Changes to Board of Directors and DSU Grant
Ralph Hesje Retires as Chairman Eric Pommer Assumes Role of Chairperson Beth Shaw Appointed to Board May 1,…
-
Voyageur Launches Market Introduction of Barium Contrast Product Line Following Successful Clinical Study Results
Positive feedback received after completion of CDC tests on 24 subjects All key product performance milestones met or…
